The Oncology Institute Warrant
TOIIW
11 hedge funds and large institutions have $479K invested in The Oncology Institute Warrant in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
42% less capital invested
Capital invested by funds: $821K → $479K (-$342K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$399 |
| 2 |
CS
Clear Street
New York
|
+$19 |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$19 |
Top Sellers
TOIIW Hedge Fund Activity: Q1 2026 in Review
11 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q1 2026, worth a combined $479K — down 42% from $821K a quarter earlier.
Fund positioning in TOIIW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $399.
- 11 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $479K of The Oncology Institute Warrant stock for Q1 2026, down 42% quarter-over-quarter.
- 0 funds opened new The Oncology Institute Warrant positions in Q1 2026 and 0 closed out.
- The largest The Oncology Institute Warrant buyer in Q1 2026 was Wolverine Asset Management, an estimated $399 added.
Based on aggregated 13F filings for Q1 2026.